p53, p21(WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 636-644

  Hsieh, J Kuang ^a   Kletsas, Dimitris ^b   Clunn, Gerard ^c   Hughes, Alun D ^a   Schachter, Michael ^c   Demoliou Mason, Catherine ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c NONE

Author keywords

Cell line; MDM2; p21(WAF1 CIP1); p53; SV 40; Vascular smooth muscle

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53; VIRUS LARGE T ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL AGING; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; VASCULAR SMOOTH MUSCLE;

EID: 0034021808     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.636     Document Type: Article

References (37)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Schwartz SM, Murry CE. Proliferation and the monoclonal origin of atherosclerotic lesions. Annu Rev Med. 1998;49:437-460.
3. Munro E, Chan P, Patel M, Betteridge L, Gallagher K, Schachter M, Sever P, Wolfe J. Consistent responses of the human vascular smooth muscle cell in culture: implications for restenosis. J Vasc Surg. 1994;20: 482-487.
4. Reilly CF. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin. J Cell Physiol. 1990;142: 342-351.
5. Legrand A, Greenspan P, Nagpal ML, Nachtigal SA, Nachtigal M. Characterization of human vascular smooth muscle cells transformed by the early genetic region of SV40 virus. Am J Pathol. 1991;139:629-640.
6. Jahn L, Sadoshima J, Greene A, Parker C, Morgan KG, Izumo S. Conditional differentiation of heart-and smooth muscle-derived cells transformed by a temperature-sensitive mutant of SV40 T antigen. J Cell Sci. 1996;109:397-407.
7. Ehler E, Jat PS, Noble MD, Citi S, Draeger A. Vascular smooth muscle cells of H-2Kb-tsA58 transgenic mice: characterization of cell lines with distinct properties. Circulation. 1995;95:3289-3296.
8. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
9. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill ME, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B. WAF1/CIP1 is induced in p-53-mediated arrest and apoptosis. Cancer Res. 1994;54:1169-1174.
10. Vojtesek B, Bartek J, Midgley CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods. 1992;151:237-244.
11. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA. 1997;94:6380-6385.
12. Harlow E, Crawford LV, Pim DC, Williamson NM. Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol. 1981;39: 861-869.
13. Borrione AC, Zanellato AM, Scannapieco G, Pauletto P, Sartore S. Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle. Eur J Biochem. 1989;183:413-417.
14. Stamps AC, Davies SC, Burman J, O'Hare MJ. Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct. Int J Cancer. 1994;57:865-874.
15. Jat PS, Sharp PA. Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol Cell Biol. 1989;9:1672-1681.
16. Fuchs B, O'Connor D, Fallis L, Sheidtmann KH, Lu X. p53 phosphorylation mutants retain transcription activity. Oncogene. 1995;10:789-793.
17. Patel MK, Betteridge LJ, Hughes AD, Clunn GF, Schachter M, Shaw RJ, Sever PS. Effects of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens. 1996;14:341-347.
18. Cristofalo VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev. 1993;73:617-638.
19. Dice JF. Cellular and molecular mechanisms of aging. Physiol Rev. 1993;73:149-159.
20. Manfredi JJ, Prives C. The transforming activity of simian virus 40 large tumor antigen. Biochim Biophys Acta. 1994;1198:65-83.
21. Shay JW, Van Der Haegen BA, Ying Y, Wright WE. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res. 1993;209:45-52.
22. Bennett MR, MacDonald K, Chan S-W, Boyle JL, Weissberg PL. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998;82:704-712.
23. Chan P, Mill S, Mulloy B, Kakkar V, Demoliou-Mason C. Heparin inhibition of human vascular smooth muscle cell hyperplasia. Int Angiol. 1992;11:261-267.
24. Wang JL, Nister M, Bongcamrudloff E, Ponten J, Westermark B. Suppression of platelet-derived growth factor alpha-and beta-receptor mRNA levels in human fibroblasts by SV40 T/T antigen. J Cell Physiol. 1996;166:12-21.
25. Mann JM, Kaski JC, Pereira WI, Arie S, Ramirez JA, Pileggi F. Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation. Heart. 1998;80:19-22.
26. Reed SI, Bailly E, Vjekosiav D, Hengst L, Resnitzky D, Slingerland J. G1 control in mammalian cells. J Cell Sci. 1994;18:69-73.
27. Chen CY, Oliner JD, Zhan Q, Fornace AJ, Vogelstein B, Kastan MB. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA. 1994;91:2684-2688.
28. Barak Y, Juven T, Haffner R, Oren M. MDM2 expression is induced by wild type p53 activity. EMBO J. 1993;12:461-468.
29. Momand J, Zambetti GP, Oslon DC, George D, Levine AJ. The MDM-2 oncogene product forms a complex with p53 protein and inhibits p53-mediated transactivation. Cell. 1992;69:1237-1245.
30. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by MDM2. Nature. 1997;387:299-303.
31. Ihling C, Haendeler J, Menzel G, Hess RD, Fraedrich G, Schaefer HE, Zeiher AM. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol. 1998;185:303-312.
32. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
33. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K, Lu X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 1997;11:1840-1852.
34. Stein GH, Dulic V. Origins of G1 arrest in senescent human fibroblasts. Bioessays. 1995;17:537-543.
35. Isner JM, Kearney M, Bortman S, Passen J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
36. Guevara NV, Kim HS, Antonova El, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 1999;5:335-339.
37. Lane D, Lu X, Hupp T, Hall PA. The role of the p53 protein in the apoptotic response. Phil Trans R Soc Land B Biol Sci. 1994;345:277-280.